Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BioHarvest Sciences ( (BHST) ) has provided an update.
On October 30, 2025, BioHarvest Sciences announced a strategic CDMO agreement with Saffron Tech Ltd., aimed at developing and commercializing saffron-derived botanical compounds. This collaboration leverages BioHarvest’s Botanical Synthesis platform and Saffron Tech’s advanced cultivation methods to produce saffron compounds more sustainably and efficiently. The agreement grants Saffron Tech a 75% ownership of the developed compositions, while BioHarvest retains 25%. This partnership is expected to revolutionize saffron production by transitioning from traditional field-based cultivation to a controlled, cell-based process, addressing global supply challenges and expanding BioHarvest’s product offerings in the nutraceutical market.
The most recent analyst rating on (BHST) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences faces significant financial challenges, with high leverage and negative equity impacting its long-term sustainability. While technical indicators show some positive momentum, the valuation remains unattractive due to ongoing losses. The earnings call provided a positive outlook with strong revenue growth and strategic initiatives, but increased expenses and net losses remain concerns.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. operates in the biotechnology industry, focusing on the development and commercialization of plant-based compounds using its patented Botanical Synthesis platform. The company is headquartered in Vancouver, Canada, and is known for its innovative approach to producing plant-based molecules without growing the plants themselves.
Average Trading Volume: 59,732
Technical Sentiment Signal: Buy
Current Market Cap: $191.2M
See more insights into BHST stock on TipRanks’ Stock Analysis page.